FPGA-based cards for data concentration and readout are often used in data acquisition (DAQ) systems for high-energy physics experiments. The DMA engines implemented in FPGA enable efficient data transfer to the processing system’s memory. This paper presents a versatile DMA engine. It may be used in systems with FPGA-equipped PCIe boards hosted in a server and MPSoC-based systems with programmable logic connected directly to the AXI system bus. The core part of the engine is implemented in HLS to simplify further development and modifications. The design is modular and may be easily integrated with the user’s DAQ logic, assuming it delivers the data via a standard AXI-Stream interface. The engine and accompanying software are designed with flexibility in mind. They offer a simple single-packet mode for debugging and a high-performance multi-packet mode fully utilizing the computational power of the processing system. The number of used DAQ cards and the amount of memory used for the DMA buffer may be modified in runtime without rebooting the system. That is particularly useful in the development and test setups. The paper also presents the development and testing methodology. The whole design is open-source and available in public repositories.

Hepatocellular carcinoma (HCC) is the most common form of liver cancer worldwide. Accumulating clinical and experimental evidence suggests the role of cyclo-oxygenase (COX) enzymes in the pathogenesis of cancers including HCC. Deuterium-enriched water (DEW) and deuterium-depleted water (DDW) play a role both in the treatment and prevention of cancers. Combination therapy using COX-inhibitors and DDW/DEW could be a rational strategy to enhance the cytotoxicity of either agent in HCC. The cytotoxicity of celecoxib or indomethacin, alone and in combination with DDW or DEW was determined in the Hep-G2 HCC cell line by MTT assay. The COX-2, MAPK pathway proteins, the anti-apoptotic Bcl2 and pro-apoptotic Bax proteins, and caspase-3 activity were determined by SDS-PAGE and western blot. Co-treatment of selective and non-selective COX-2 inhibitors with DEW led to a remarkable increase in cytotoxicity and apoptosis of Hep-G2 cells. These events were associated with the activation of p38 and JNK MAPKs and a decrease in pro-survival proteins Bcl-2, COX-2, and ERK1/2. Furthermore, the combination therapy activated caspase-3, and the apoptosis mediator, and disabled poly ADP-ribose polymerase (PARP), the key DNA repair enzyme, by cleaving it. The combination of DEW with NSAIDs might be effective against HCC cells by influencing principal cell signaling pathways, and this has a potential to become a candidate for chemotherapy.

Hypercholesterolemia is a major risk for the development of cardiovascular diseases (CVDs), the main cause of mortality worldwide, and it is characterized by high levels of circulating cholesterol. The drugs currently available for hypercholesterolemia control have several side effects, so it is necessary to develop new effective and safer therapies. Seaweeds serve as sources of several bio-active compounds with claimed beneficial effects. Eisenia bicyclis (Aramé) and Porphyra tenera (Nori) are edible seaweeds which were previously recognized as rich in bioactive compounds. In the present study, we aim to evaluate the anti-hypercholesterolemia effect of these two seaweeds ex-tracts and their health potential. Both extracts, but more efficiently Aramé extract demonstrated to have liver 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) inhibitory activity and to reduce approximately 30 % cholesterol permeation through human Caco-2 cells simulating the intestinal lining, targets for hypercholesterolemia treatments. An untargeted metabolomic assay on human intestinal Caco-2 and liver Hep-G2 cells lines exposed to Aramé and Nori extracts revealed changes in the cell’s metabolism as indicators of the extract’s health beneficial effects. The metabolic pathways affected by exposure to both extracts were associated to lipid metabolism, such as phospholipids, and fatty acid metabolism, pathways of amino acid, cofactors and vitamins and cellular respiration metabolism. More profound for Aramé treated cells, but also seen for Nori ex-posed cells, the metabolites modifications were associated with the protection against CVDs and other diseases and, to the improvement of cells oxidative stress tolerance. The results obtained for the anti-hypercholesterolemia properties, in addition to the revelation of the positive impact on cells metabolism, are an important contribution for further evaluation of these seaweeds extracts as functional foods or for CVDs prevention.

The firmware developed for the readout and trigger processing of the information emerging from BIS78-RPC Muon Spectrometer chambers in the ATLAS experiment at CERN, is presented here, together with data processing techniques, data acquisition software and tests of the readout chain system, on the road to make these chambers operational in the ATLAS experiment. This work is performed in the context of the BIS78-RPC project, which deals with the pilot deployment of a new generation of sMDT+RPC chambers in the experiment. Such chambers are planned to be fully deployed in the whole barrel inner layer of the Muon Spectrometer during the Phase-II upgrade of the ATLAS experiment. On-chamber front-ends include an amplifier, a discriminator ASIC and an LVDS transmitter. The signal is digitized by CERN HPTDC chips and then processed by an FPGA which is the heart of the readout and trigger processing, using various techniques. The work presented here is a continuation of the work presented in [1].